His primary scientific interests are in Major histocompatibility complex, MHC class I, Cell biology, Molecular biology and MHC restriction. His studies in Major histocompatibility complex integrate themes in fields like T cell, Antigen presentation and CD8. MHC class I is a subfield of Genetics that he explores.
His Cell biology research incorporates themes from Antigen processing and Transporter associated with antigen processing. His studies in Molecular biology integrate themes in fields like Mitogen-activated protein kinase and Peptide sequence. As a part of the same scientific family, Nilabh Shastri mostly works in the field of MHC restriction, focusing on Peptide and, on occasion, Cytotoxic T cell and CTL*.
His primary areas of study are MHC class I, Major histocompatibility complex, Antigen, Antigen presentation and Molecular biology. His MHC class I study combines topics from a wide range of disciplines, such as Peptide and Cell biology. His biological study spans a wide range of topics, including Cytotoxic T cell, Antigen-presenting cell and CD8.
Nilabh Shastri studied Antigen and Virology that intersect with Toxoplasma gondii. His Molecular biology research is multidisciplinary, incorporating elements of T-Cell Receptor Beta Chain, T cell, MHC class II, T-cell receptor and Transfection. His research in Antigen processing focuses on subjects like Endoplasmic reticulum, which are connected to Aminopeptidase.
Nilabh Shastri mainly investigates MHC class I, Major histocompatibility complex, Antigen presentation, Antigen and Cytotoxic T cell. Nilabh Shastri interconnects Biophysics, Peptide and Cell biology in the investigation of issues within MHC class I. His work carried out in the field of Major histocompatibility complex brings together such families of science as Molecular biology and T cell.
His work deals with themes such as CD1, Intracellular parasite and Virology, which intersect with Antigen. Within one scientific family, Nilabh Shastri focuses on topics pertaining to CD8 under Virology, and may sometimes address concerns connected to Toxoplasma gondii, Chronic infection and T-cell receptor. His Cytotoxic T cell research integrates issues from Epitope and Computational biology.
Nilabh Shastri mostly deals with Major histocompatibility complex, Cytotoxic T cell, Antigen presentation, Peptide and Epitope. Nilabh Shastri is involved in the study of Major histocompatibility complex that focuses on MHC class I in particular. His Antigen processing study in the realm of MHC class I connects with subjects such as Repertoire.
His Epitope research includes themes of Intracellular parasite and Immunogenicity. Nilabh Shastri focuses mostly in the field of Antigen, narrowing it down to matters related to Virology and, in some cases, Immunology. His Aminopeptidase research includes elements of Molecular biology, Peptide binding, Minor histocompatibility antigen and Transfection.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I.
Shelley R. Starck;Vivian Jiang;Mariana Pavon-Eternod;Sharanya Prasad.
Science (2012)
Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.
Nilabh Shastri;F. Gonzalez.
Journal of Immunology (1993)
Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum
Nicolas Blanchard;Federico Gonzalez;Marie Schaeffer;Nathalie T Joncker.
Nature Immunology (2008)
Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER.
Pedro Paz;Nathalie Brouwenstijn;Robin Perry;Nilabh Shastri.
Immunity (1999)
Tyrosyl phosphorylation and activation of MAP kinases by p56lck.
Elham Ettehadieh;Jasbinder S. Sanghera;Steven L. Pelech;Denise Hess-Bienz.
Science (1992)
Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins
Sarah Sanderson;Kenneth Frauwirth;Nilabh Shastri.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Presentation of Out-of-Frame Peptide/MHC Class I Complexes by a Novel Translation Initiation Mechanism
Subramaniam Malarkannan;Tiffany Horng;Patty P Shih;Susan Schwab.
Immunity (1999)
ERAAP Synergizes with MHC Class I Molecules to Make the Final Cut in the Antigenic Peptide Precursors in the Endoplasmic Reticulum
Takayuki Kanaseki;Nicolas Blanchard;Gianna Elena Hammer;Federico Gonzalez.
Immunity (2006)
Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex.
Lisa M Mendoza;Pedro Paz;Aamir Zuberi;Greg Christianson.
Immunity (1997)
All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway
Nilabh Shastri;Sylvain Cardinaud;Susan R. Schwab;Thomas Serwold.
Immunological Reviews (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, Berkeley
Tufts University
National Institutes of Biomedical Innovation, Health and Nutrition
Jinan University
Virginia Mason Medical Center
Sapporo Medical University
Hokkaido University
University of Oxford
University of Tokushima
University of Rochester Medical Center
University of Oulu
Virginia Tech
Brookhaven National Laboratory
University of Vermont
Nanyang Technological University
Oregon State University
Weizmann Institute of Science
University of Massachusetts Amherst
University of Tokyo
University of Michigan–Ann Arbor
University of Alaska Fairbanks
Birkbeck, University of London
University of Oslo
Brigham and Women's Hospital
London School of Economics and Political Science
University of South Florida